Appointments at Xcellerex, Bristol-Myers Squibb and KV Pharmaceutical – People on the move

By Nick Taylor

- Last updated on GMT

Related tags: Bristol-myers squibb, Medicine, Management occupations

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Xcellerex, Bristol-Myers Squibb and KV Pharmaceutical.

Xcellerex ​has named Guy Broadbent ​as president and CEO. During his 25 year career Broadbent has gained substantial experience of the life sciences sector, most recently at Thermo Fisher Scientific.

Charles Bancroft ​has been elected chief financial officer (CFO) of Bristol-Myers Squibb​ (B-MS) by the company’s board of directors. Bancroft joined B-MS in 1984 and has since held positions of increasing responsibility in the company’s finance organisation.

MicroCHIPS​ has appointed Ajit Gill​ as president and CEO. Gill joins MicroCHIPS from Auspex Pharmaceuticals and also spent 14 years at Nektar Therapeutics, leading the company as it grew from a start-up to a public biopharmaceutical business.

Robert O’Holla ​has joined CeQur SA ​as executive vice president (EVP) for regulatory affairs. O’Holla worked at Johnson & Johnson for 33 years, including 18 years as worldwide VP for regulatory affairs.

KV Pharmaceutical​ has named Stephen Stamp ​as CFO and treasurer. Stamp has 27 years of finance experience at companies including Xanodyne Pharmaceuticals and Shire Pharmaceuticals.

Robert Forrester ​has been appointed chief operating officer at Forma Therapeutics​. Forrester has previously worked at CombinatoRx and Coley Pharmaceutical.

Dendreon ​has named Varun Nanda​ as SVP of global operations. Nanda was previously SVP and global head of oncology operations at Roche/Genentech.

Dipak Panigrahi ​has joined QLT​ as SVP, research and development and chief medical officer. Panigrahi has previously worked at Alcon Laboratories and Merck & Co.

Inspire Pharmaceuticals​ has appointed Andrew Koven ​to the newly created position of EVP and chief administrative and legal officer. Koven has previously worked at Sepracor, Kos Pharmaceuticals and Lavipharm.

Related topics: Markets & Regulations

Related news

Show more

Follow us


View more